ARTICLE | Company News
Australia approves cladribine tablets
September 3, 2010 11:32 PM UTC
The Australian Therapeutic Goods Administration (TGA) approved Movectro cladribine tablets from Merck KGaA (Xetra:MRK) to treat relapsing-remitting multiple sclerosis (RRMS). The purine nucleoside ana...